I thought that the article Clare Gerada wrote for the BJGP was beautifully written and perfectly expressed.1 My mother (Ann McPherson) was a GP who felt strongly through her career that she could not do enough for patients who had a terrible time while they were dying. Unfortunately her death from pancreatic cancer, despite optimal palliative care, was prolonged and unpleasant. It is a difficul...

RFC 3777 defines the Nominations and Recall Committee’s (NomCom’s) operation, and includes a sample timeline for major steps in the NomCom process that meets the minimum normative requirements for the process. Recent NomComs have been scheduling based on the sample timeline, and the chairs of the last three NomComs -Danny McPherson (2004-2005), Ralph Droms (2005-2006), and Andrew Lange (2006-20...

von Bonsdorff-Nikander, A.K., 2005. Studies on a cholesterol-lowering microcrystalline phytosterol suspension in oil Dissertationes bioscientiarum molecularium Universitatis Helsingiensis in Viikki, 2/2005, 55 pp., ISBN 952-10-2289-2 (print) ISBN 952-10-2290-6 (pdf) ISSN 1239-9469 Some cholesterol-lowering drugs have lately caused severe side-effects in humans and the potential use of phytoster...

kinematic synthesis of a trailing six-member mechanism has been carried out to achieve five precision points of an automotive steering mechanism. the inner wheel can be rotated up to forty five degrees with fair accuracy. results show that the divergent end behavior of ackermann steering mechanism has been overcome by the present mechanism. the work is similar to earlier work by the present aut...

The purpose of this memo is to document how the requirements for advancing a routing protocol from Draft Standard to full Standard have been satisfied by Border Gateway Protocol version 4 (BGP-4). This report satisfies the requirement for "the second report", as described in Section 6.0 of RFC 1264. In order to fulfill the requirement, this report augments RFC 1773 and describes additional know...

Under 5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,747 5.9 5 to 9 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,902 6.4 10 to 14 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,336 7.9 15 to 19 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,598 8.8 20 to 24 years . . . . . . . . . . . . . . . . ....